在四个非洲国家实施的药物监督混合电子学习培训计划的开发,评估和教育影响
Francesco Schievano1, Kissa W Mwamwitwa2, Seth Kisenge2
1Section of Pharmacology, Department of Diagnostics and Public Health, University of Verona, Verona, Italy.
Frontiers in medicine
|May 2, 2024
概括
非洲PhAmacoVIgilance (PAVIA) 项目成功培训了医疗保健专业人员使用电子学习对抗结核病药物的药物监测,改善了非洲几个国家的知识和报告.
科学领域:
- 药物监督 药物监督 药物监督
- 全球健康 全球健康
- 制药科学 制药科学
背景情况:
- 改善低收入和中等收入国家,特别是撒哈拉以南非洲国家的药物准入,在药物监管系统中面临挑战.
- 非洲PhAmacoVIgilance (PAVIA) 项目旨在加强药物监测,特别是针对坦桑尼亚,埃斯瓦蒂尼,尼日利亚和埃塞俄比亚的抗结核药物.
- 由于COVID-19大流行,培训交付方法的调整成为必要.
研究的目的:
- 评估PAVIA电子学习培训计划对药物监测的有效性.
- 评估该计划在COVID-19大流行期间的适应性和影响.
- 测量知识获取,学习者满意度,以及对不良事件自发报告的影响.
主要方法:
- 开发了一个混合电子学习计划,包括两个课程和一个教育平台.
- 实施了培训员培训模式.
- 通过使用测试前和测试后的分数,学习者问卷和分析VigiBase中的个人病例安全报告 (ICSRs) 来评估计划的有效性.
主要成果:
- 121名学习者参加了试点培训,在所有四个国家都观察到显著的知识增长 (测试后的分数高于测试前).
- 随后在坦桑尼亚,埃斯瓦蒂尼和尼日利亚进行了下一步培训,培训了827名学习者,获得了积极的反和改善的测试后成绩.
- 定性分析表明,在培训后,坦桑尼亚,埃斯瓦蒂尼和尼日利亚的ICSR数量大幅增加.
结论:
- 帕维亚电子学习计划有效地提高了参与非洲国家的医疗保健专业人员的药监知识.
- 学习者的反是极为积极的,表明了对课程的满意度.
- 虽然很难确定直接的因果关系,但这项培训可能导致了不良事件报告的增加,尽管其他因素,如COVID-19疫苗报告,也可能影响了这种情况.
相关概念视频
Pharmacovigilance
829
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
829
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
Analysis of Population Pharmacokinetic Data
252
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
252
Drug Control Governance: Regulatory Bodies and Their Impact
157
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
157
Biopharmaceutics and Pharmacokinetics: Overview
2.0K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
2.0K
Drug Administration and Therapy Phases: Overview
452
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
452


